NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical technology solutions, today announced that GlaxoSmithKline (GSK) has decided to implement Medidata Designer®, an innovative study design optimization solution, for its Clinical Research and Development organization. Using Designer, GSK can consistently design studies that meet key objectives and collect necessary data in a streamlined and efficient manner.
